Neurocode Labs Inc.
Know More Now®
We specialize in neurologic disorders for which genetic testing can accelerate patient diagnosis and improve treatment.

Learn more about us

ABOUT Neurocode Labs, Inc.

Neurocode Labs, Inc. is dedicated to offering sequencing to help determine the influence of genetics on neurological disease, and furthering the understanding of genetics in the practice of both pediatric and adult neurology. We also offer clients the opportunity to further the understanding of various neurological disorders by requesting they allow us to contribute data to ongoing research efforts in areas such as seizure disorders, dementia, and parkinsonism.

Whole Exome Sequencing

We target the coding sequence of the human genome, and then focus on a set of genes either known or suspected to be associated with various neurological conditions.


We maintain, mine and ethically share genetic knowledge for maximum benefit. Exome sequencing may yield a lifetime of insight, to individuals and society. Research is performed with the University of British Columbia and the global community of professionals, patients and public who care.

Story of Gavin

“In genetic medicine, our goals are to promote rapid innovation and provide accurate, clinically meaningful results." - Matthew Farrer

Download Gavin's Story




Hans Frykman, MD, PhD

CEO & Founder

Dr. Frykman holds a M.Sc. in chemical engineering from Chalmers University, a Ph.D. in biocatalysis from royal institute of technology, Sweden, and received his M.D. from the Karolinska institute in 2006, with postgraduate medical training at the Karoliska University hospital, the University of Minnesota, the Mayo clinic, Sloan Kettering, and the University of British Columbia. he is a member of the FRCPC and the BC College of Physicians and Surgeons.


Matt Farrer, PhD

CSO & Founder

Prof. Farrer has a Bachelor’s degree in biochemistry from King’s College London, and a Ph.D. in human genetics from St. Mary’s Hospital Medical School, Imperial College London, UK. He did post-doctoral fellowships at the Kennedy-Galton Centre of Medical and Community Genetics, and at Mayo Clinic.


Ilaria Guella, PhD


Dr. Guella is a human molecular geneticist whose research interests are primarily directed at understanding how genetic variability acts on neurodegenerative diseases. She received her Ph.D. in molecular and cellular biology from the University of Milan, Italy and then completed a post-doc at the Department of Psychiatry and Human Behavior at the University of California, Irvine. In 2013 Ilaria joined the the Centre for Applied Neurogenetics at the University of British Columbia, where she currently works as a research associate.


Dan Evans


Dan received his B.Sc. in Computer and Information Science from Queen's University in 2000. He has 15 years of experience in health informatics, including public health, proteomics, genomics and clinical genetics.


Yanwei Xi, PhD

Lab Director

Dr. Xi has a Ph.D. in Developmental Neuroscience from University of Ottawa. He did postdoctoral research in human molecular genetics at the Children’s Hospital of Eastern Ontario, and CCMG training in Clinical Molecular Genetics at the Alberta Children’s Hospital. He is a Diplomate of the American Board of Medical Genetics and Genomics and a Fellow of the American College of Medical Genetics and Genomics.


Neurocode Labs, Inc. offers testing centred around the practice of neurology. Physicians can request sample kits and order testing for their patients. Our testing is done by whole exome sequencing, which is then focused on a set of genes either known or suspected to be associated with various neurological conditions. Up to three likely causative or pathogenic mutations associated with the phenotype will be validated by Sanger sequencing, and a report will be returned to the referring physician. Turn-around time for all testing is eight weeks. No STAT test ordering is currently available. To request information or advice regarding the testing we offer, or the proper testing to order, please contact us. The full results of exome sequencing can be made available to the physician for more comprenensive genetic counselling or investigation, as well as any research collaborations to which the patient has consented.

Test Requisition Forms

MSP-funded whole exome sequencing

  • Neurocode Labs, Inc. has suspended operations until February 1, 2019 to focus on reaccreditation.

Privately paid whole exome sequencing:

Privately paid Sanger sequencing confirmation of previously-identified variants

Instructions for filling out the test requisition are available here (requires PDF reading software).

Available Tests

  • Exome Sequencing for Epilepsy and Seizure Disorders
  • A set of 620 genes is interrogated for both known and potentially novel causative mutations. Please see the list of covered genes here.

    This test also includes bioinformatics analysis, periodic re-reporting, and one Sanger validation of a potentially causative mutation.

    Cost: $3500 CAD

  • Sanger Validation
  • Neurocode Labs, Inc. also offers clinical confirmation of mutations discovered in other facilities. Results will be returned to the requesting facility.
    This service is included for all MSP-funded testing, but is also offered on a fee-for-service basis.

    Cost: $300 CAD per variant in one individual, plus $50 CAD per additional individual. Sanger validation in a parent-child trio would cost $400 CAD.

Sequencing Questions and Interpretation

Neurocode Labs, Inc. is dedicated to ensuring all questions regarding the results of the sequencing we perform are answered. Medical, scientific, technical and informatics experts are all available to answer any questions our clients may have about any of our processes; the applicability and reliability of results; and the processes involved behind the data we generate. If you have questions, please do not hesitate to contact us.

Usage of Referral Laboratories

Accuracy and reliability of sequencing results are the most important part of Neurocode's laboratory operations. At certain times, Neurocode Labs may need to send a sample submitted to us to a referral laboratory for sequencing at no additional cost to the user. If this happens, users or laboratory services will be notified before the sample is sent, and the results of that testing will be included in the report Neurocode Labs sends back.

At present, Neurocode Labs does not send any samples to referral labs for sequencing. Please contact us if you have questions about the referral lab process.



Neurocode Laboratory, Inc.
Attn: Dr Matthew Farrer
5524-2405 Wesbrook Mall
Vancouver BC
V6T 1Z3

We accept packages on regular work days, Monday through Friday. Please do not request Saturday delivery. For international shipping, a commercial (ProForma) invoice is required on the outside package along with the waybill. A sample invoice for DNA is available. Please be sure to also include a customs declaration form.

Blood, DNA and saliva samples can be shipped at room temperature. For blood and DNA samples, express delivery is recommended. Blood samples collected on a Friday or over the weekend should be kept at 4°C and shipped on the next business day with overnight delivery. Keeping the specimen refrigerated over the weekend will not compromise sample quality.

Package the specimen(s) according to approved transportation policies. Include the completed test requisition form in the shipping container. Ensure name and identifying number on the specimen match those on the test requisition form and clearly indicate the test being ordered. Incomplete forms will result in either delay of testing, or sample rejection. Incorrectly stored or transported samples will result in sample rejection.

Sample Requirements

Fresh peripheral whole blood is our preferred specimen type. We also accept saliva as well as DNA. We offer kits for either blood or saliva specimen collection; please contact us at to request a kit.


Neurocode Labs, Inc. is incorporated under the laws of British Columbia, Canada. Our provincial business number is BC1042695.

Neurocode Labs, Inc. is accredited as a Molecular Diagnostic Laboratory under British Columbia's Diagnostic Accreditation Program. Our certificate number is 061301, expiry 2019-03-14.

Dr. Frykman is licensed to practice medicine in British Columbia. College of Physicians and Surgeons of BC ID: 29971, registration number: 50041.

Neurocode labs, Inc. Incorporation

Laboratory Accreditation

Professional Licensure


Let's get in touch. Send us a message:

Neurocode Labs, Inc.
2405 Wesbrook Mall, Rm 5524
Vancouver, BC V6T 1Z3 Canada
For general inquiries, comments, questions, or concerns.

Monday - Friday 9:00 to 17:00 (Closed all statutory holidays)

The lab is not open to the public; we have no facilities to perform sample draws from patients. Please see our Tests and Sending Samples pages for details on how to submit samples for sequencing.